Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10230006

Pulse compression for finite amplitude distortion based harmonic imaging using coded waveforms.

P C Li
View original source ↗Export metadata ↓

Abstract

Finite amplitude distortion based harmonic imaging has been used to reduce the image quality degradation produced by tissue inhomogeneities. Such harmonic signals are significantly lower than the linear components and are possibly too low compared to the dynamic range of the imaging system. To improve signal-to-noise ratio (SNR) without exceeding regulatory limits, coded excitation is explored. In addition, pulse compression schemes suitable for finite amplitude distortion based harmonic imaging are also developed. Note that due to the differences in harmonic generation, these compression schemes are different from those proposed for harmonic imaging using contrast agents. In this paper, simulation examples of SNR improvements by up to 8.2 dB are shown and the efficacy of the compression schemes is studied. Potential sources of performance degradation are also discussed.

Explore related subjects

Contrast MediaHumansModels, TheoreticalPhantoms, ImagingUltrasonographyJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P C Li. 1999. Pulse compression for finite amplitude distortion based harmonic imaging using coded waveforms.. https://doi.org/10.1177/016173469902100101

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Type, severity, frequency and management of adverse reactions associated with ultrasound contrast agents: a systematic review and meta-analysis.

OBJECTIVES: This systematic review and meta-analysis are aimed at evaluating the incidence of adverse drug reactions (ADRs) following administration of clinically approved ultrasound contrast agents (UCAs) in adults and children, to assess risks in patients with cardiovascular disease and in pregnancy, and to evaluate the effectiveness of emergency management of severe ADRs. MATERIALS AND METHODS: A PRISMA 2020 systematic review was conducted searching PubMed, Scopus, and Embase. Two reviewers independently screened, extracted data, and assessed quality. Incidence estimates were pooled when feasible, stratified by age group, contrast agent, and administration route. RESULTS: Seventy-four studies encompassing >&#x2009;1 million adults and >&#x2009;36,000 children were included, contributing multiple analytic cohorts to the quantitative synthesis. Severe acute ADRs were extremely rare (6 and 16 cases per 100,000 in adults and children, respectively) and absent following endocavitary administration in children. Non-severe acute ADRs occurred in 11 and 8 cases per 10,000 adults and children, respectively. Delayed reactions were very rare (<&#x2009;1 case per million in adults). No significant safety differences emerged between UCA products. The incidence of ADRs in patients with cardiovascular disease was analogous to the general population. No ADRs were reported in pregnant women. Standard emergency management was effective in almost all serious cases, though rare fatalities occurred. CONCLUSION: UCAs show an excellent safety profile in adults and children, with very rare severe ADRs and few non-severe, typically self-limiting reactions. Strict adherence to recommended emergency management protocols mitigates the remaining risks, supporting safe use across a broad range of clinical indications. PROSPERO REGISTRATION: CRD42023432668. KEY POINTS: Question What is the incidence, type, and severity of acute and delayed ADRs associated with clinically approved UCAs across different patient populations? Findings Severe acute adverse reactions are very rare, and non-severe reactions are rare and self-limiting, with no significant safety differences between adults, children, or patients with cardiovascular disease. Clinical relevant UCAs show an excellent safety profile across populations. These findings support their safe clinical use as reliable alternatives to iodine-based and gadolinium-based contrast agents in routine diagnostic imaging.

Contrast Media↗
PubMed2003

Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.

Insulinoma is the most common pancreatic endocrine tumor. Localization of small tumors remains a diagnostic challenge. Recently, Mangafodipir-enhanced MR imaging using a whole-body coil has been shown to be effective in the detection and staging of pancreatic cancer [3]. Localization of even small tumors is improved and surgical techniques, such as robotic-assisted surgery, have been made possible.

Contrast Media↗